Article
Late-stage RSV vaccine trials show 'exciting promise,' some scientists say | CNN
Rating:
0.0
Views:
43
Likes:
1
Library:
1
A Pfizer vaccine to protect older adults and infants from respiratory syncytial virus (RSV) infection has shown what some scientists are calling "exciting" promise in late-stage trials.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value